UA108478C2 - Vesicles form storage for treating inflammatory dermatoses - Google Patents

Vesicles form storage for treating inflammatory dermatoses

Info

Publication number
UA108478C2
UA108478C2 UAA201203401A UAA201203401A UA108478C2 UA 108478 C2 UA108478 C2 UA 108478C2 UA A201203401 A UAA201203401 A UA A201203401A UA A201203401 A UAA201203401 A UA A201203401A UA 108478 C2 UA108478 C2 UA 108478C2
Authority
UA
Ukraine
Prior art keywords
inflammatory dermatoses
treating inflammatory
form storage
vesicles form
vesicles
Prior art date
Application number
UAA201203401A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Henk-Andre Kroon
William Henry
Original Assignee
Targeted Delivery Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targeted Delivery Technologies Ltd filed Critical Targeted Delivery Technologies Ltd
Priority claimed from PCT/US2010/046245 external-priority patent/WO2011022707A1/en
Publication of UA108478C2 publication Critical patent/UA108478C2/en

Links

Abstract

Винахід належить до складу у вигляді везикул для лікування запальних дерматозів, що містить один або більше фосфоліпідів й одну або більше неіоногенних поверхнево-активних речовин під час відсутності якого-небудь фармацевтично активного агента, відмінного від ліпіду та поверхнево-активної речовини. Винахід також належить до способу лікування запальних дерматозів та упакування заявленого складу.The invention relates to vesicles for the treatment of inflammatory dermatoses containing one or more phospholipids and one or more nonionic surfactants in the absence of any pharmaceutically active agent other than lipid and surfactant. The invention also relates to a method of treating inflammatory dermatoses and packaging the claimed composition.

UAA201203401A 2009-08-21 2010-08-20 Vesicles form storage for treating inflammatory dermatoses UA108478C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23599209P 2009-08-21 2009-08-21
PCT/US2010/046245 WO2011022707A1 (en) 2009-08-21 2010-08-20 Vesicular formulations

Publications (1)

Publication Number Publication Date
UA108478C2 true UA108478C2 (en) 2015-05-12

Family

ID=53674411

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201203401A UA108478C2 (en) 2009-08-21 2010-08-20 Vesicles form storage for treating inflammatory dermatoses

Country Status (1)

Country Link
UA (1) UA108478C2 (en)

Similar Documents

Publication Publication Date Title
EA202191559A1 (en) MODIFIED AMINE LIPIDS
ECSP13012534A (en) PHARMACEUTICAL COMPOSITION
CL2013003214A1 (en) Stable formulation comprising at least one monoclonal antibody that specifically binds to pcsk9, a buffer, a surfactant and at least one stabilizer; and its use to treat or prevent cholesterol-related diseases.
MX2011008204A (en) Methods of reducing the proliferation and viability of microbial agents.
WO2012065958A9 (en) Method of treating contrast-induced nephropathy
CL2012000446A1 (en) Use of a topical vesicular formulation comprising one or more phospholipids and one or more surfactants in a molar ratio of 1: 1 to 25: 1 phospholipids to surfactants, for the treatment of inflammatory dermatous disorders.
MX2015011955A (en) Lipids and lipid compositions for the delivery of active agents.
PE20142314A1 (en) INTRANASAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
WO2013165725A8 (en) Unit-dose format perhydrolase systems
WO2011132089A3 (en) Methods for tissue decellularization
MX2015017375A (en) Personal care compositions and articles.
PE20140255A1 (en) DISPERSIBLE TABLET IN ORAL FORM
BR112014005190A2 (en) microcapsule compositions comprising ph-adjustable di-starch gelling agents
TW200942530A (en) Pyridine compounds
NZ702934A (en) Racecadotril lipid compositions
BR112012007798A2 (en) stable microcapsules and composition for topical application and method for preparing microcapsules
WO2010068917A3 (en) Compositions and methods for promoting vascular barrier function and treating pulmonary fibrosis
BR112012021418A2 (en) toilet cleaner and method.
GB2487339A (en) Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
CL2012001636A1 (en) Mesalamine rectal suppository, where the mesalamine particles have a surface area of 0.1 m2 / g to 1.3 m2 / g, useful in the treatment of active ulcerative proctitis.
MX2010004962A (en) Homogeneous and storage-stable mixtures of different active plant protection agent granule particles.
MA30711B1 (en) BENZIMIDAZOLYL PYRIDYL ETHER SALTS AND ASSOCIATED FORMULATIONS
BR112014014576A2 (en) non-surfactant aqueous composition, emulsion composition, displacement method of an unrefined active petroleum material in contact with a solid material, and method of converting an unrefined active petroleum acid into a surfactant
MY162688A (en) Oral care compositions
RU2013110517A (en) MEANS FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHEPATITIS